SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-009728
Filing Date
2020-02-14
Accepted
2020-02-14 16:56:32
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3407
  Complete submission text file 0001209191-20-009728.txt   5007
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTRABIOTICS PHARMACEUTICALS INC 1009 OAK HILL ROAD, SUITE 201 LAFAYETTE CA 94549
Business Address
Quart Barry D (Reporting) CIK: 0001384243 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-33221 | Film No.: 20621465